Creative Life Science Co (ROCO:7837) ROE %: 20.90% (As of Dec. 2025) — Near Median


ROCO:7837 Creative Life Science Co Ltd ROCO:7837
20 GF Score
Price NT$87.80
! 2 Warning Signs
View Full Analysis

What is Creative Life Science Co ROE %?

Creative Life Science Co ROCO:7837 -1.13% 20 ROE % is 20.90% as of Dec. 2025, which is 7% above its 10-year median of 19.58. GuruFocus rates ROCO:7837 with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 1,250 Biotechnology companies, Creative Life Science Co ranks better than 92.24% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Creative Life Science Co's annualized net income for the quarter that ended in Dec. 2025 was NT$142 Mil. Creative Life Science Co's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was NT$681 Mil. Therefore, Creative Life Science Co's annualized ROE % for the quarter that ended in Dec. 2025 was 20.90%.

The historical rank and industry rank for Creative Life Science Co's ROE % or its related term are showing as below:

ROCO:7837' s ROE % Range Over the Past 10 Years
Min: 17.61   Med: 19.58   Max: 36.52
Current: 17.92

During the past 5 years, Creative Life Science Co's highest ROE % was 36.52%. The lowest was 17.61%. And the median was 19.58%.

ROCO:7837's ROE % is ranked better than
92.24% of 1250 companies
in the Biotechnology industry
Industry Median: -38.26 vs ROCO:7837: 17.92

Creative Life Science Co  (ROCO:7837) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=142.24/680.691
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(142.24 / 1189.708)*(1189.708 / 1365.6995)*(1365.6995 / 680.691)
=Net Margin %*Asset Turnover*Equity Multiplier
=11.96 %*0.8711*2.0063
=ROA %*Equity Multiplier
=10.42 %*2.0063
=20.90 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=142.24/680.691
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (142.24 / 168.654) * (168.654 / 178.66) * (178.66 / 1189.708) * (1189.708 / 1365.6995) * (1365.6995 / 680.691)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8434 * 0.944 * 15.02 % * 0.8711 * 2.0063
=20.90 %

Note: The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Creative Life Science Co ROE % Related Terms


Creative Life Science Co ROE % Historical Data

* Premium members only.

The historical data trend for Creative Life Science Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creative Life Science Co ROE % Chart

Creative Life Science Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
0.00 36.52 18.34 20.81 17.61

Creative Life Science Co Semi-Annual Data
Dec21 Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Get a 7-Day Free Trial 0.00 27.16 17.82 15.03 20.90

ROCO:7837 vs VRTX, REGN, ALNY: ROE % Comparison

For the Biotechnology subindustry, Creative Life Science Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creative Life Science Co ROE % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Creative Life Science Co's ROE % distribution charts can be found below:

* The bar in red indicates where Creative Life Science Co's ROE % falls into.


ROCO:7837
20GF Score
Creative Life Science Co Ltd ROCO:7837
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Creative Life Science Co ROE % Calculation

Creative Life Science Co's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=118.398/( (621.014+723.948)/ 2 )
=118.398/672.481
=17.61 %

Creative Life Science Co's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Jun. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=142.24/( (637.434+723.948)/ 2 )
=142.24/680.691
=20.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 20.90% mean?
Creative Life Science Co (ROCO:7837) has a ROE % of 20.90% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Creative Life Science Co and its competitors. This is near median its historical median of 19.58. Over the past decade, Creative Life Science Co's ROE % has ranged from 17.61 to 36.52. According to the industry distribution chart, Creative Life Science Co ranks #97 out of 1250 companies in the Biotechnology industry, placing it in the top 7.8%.
Is Creative Life Science Co's ROE % too high?
Creative Life Science Co's current ROE % of 20.90% is near median its 10-year median of 19.58. Over the past 10 years, this metric has ranged from a low of 17.61 to a high of 36.52. Based on the distribution chart, Creative Life Science Co ranks #97 out of 1250 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Creative Life Science Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Creative Life Science Co's ROE % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Creative Life Science Co ranks #97 out of 1250 companies for ROE %. This places Creative Life Science Co in the top 8% of its industry — outperforming the majority of peers. Historically, Creative Life Science Co's own ROE % has ranged from 17.61 to 36.52 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Biotechnology company?
A good ROE % depends on the Biotechnology industry context. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Creative Life Science Co and its competitors. Creative Life Science Co's current ROE % is 20.90%, which is near median its own 10-year median of 19.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creative Life Science Co stock overvalued right now?
Creative Life Science Co (ROCO:7837) has a current ROE % of 20.90%. The current ROE % is 20.90%, which is near median its 10-year median of 19.58. Creative Life Science Co's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Creative Life Science Co (ROCO:7837), the current ROE % is 20.90% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Creative Life Science Co Business Description

Address Wuquan 3rd Road, No. 24, Wugu District, New Taipei City, TWN, 248021
Creative Life Science Co Ltd is engaged in providing products of microbiology, and it has prepared media products and diagnostic reagents. The main products of CMP (Creative Media Plate) are solid and liquid media, which can be used for clinical microbiology, basic microbial research, environmental monitoring, biosafety testing, and quality control. Its product line is Transport Medium, Prepared Tube Media, Prepared Plated Media, VTM & I-VTM, Bacterial strain preservation system, and CMP SteriPack triple wrapped media.
20GF Score

Get the complete analysis for ROCO:7837

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$87.80
Price